Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole. - Wikidata - wikimedia - TriplyDB

Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.

Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.

http://www.wikidata.org/entity/Q37248763

about

Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial.An open-label, randomized, cross-over bioequivalence study of lafutidine 10 mg under fasting condition

P2860

Q35039951-A3F36FBE-2F43-4FFF-98C5-8B3338EF88DC Q41914881-4D799AE0-4591-4649-A114-52D3C44E85EB

P2860

Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.

http://www.wikidata.org/entity/Q37248763

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Stronger inhibition of gastric ...... n pump inhibitor lansoprazole.

@en

Stronger inhibition of gastric ...... n pump inhibitor lansoprazole.

@nl

type

label

Stronger inhibition of gastric ...... n pump inhibitor lansoprazole.

@en

Stronger inhibition of gastric ...... n pump inhibitor lansoprazole.

@nl

prefLabel

Stronger inhibition of gastric ...... n pump inhibitor lansoprazole.

@en

Stronger inhibition of gastric ...... n pump inhibitor lansoprazole.

@nl

P1433

Q37248763-D3948D60-7A99-4415-894A-17B33E88F33D

P1476

Q37248763-4908A196-4592-400B-B261-645160959646

P2093

Q37248763-47BC4824-3F6D-43B7-A0FF-188A2FDF8321

Q37248763-4F9701F8-E636-4237-8765-F600D6E4DB6E

Q37248763-558CBA3B-671C-4B2A-85FA-15D021A03BBA

Q37248763-6EE30208-81C3-48D1-8801-9E1C988900DB

Q37248763-79C4960B-79BA-40A0-BB00-1736F680F899

Q37248763-A6C16825-BC05-4DA1-824E-160E50BD52EE

Q37248763-A8D06498-8EAC-469E-B1C5-53DA2B7C9392

Q37248763-D280FA58-7046-4999-9C03-4AA3EB330D06

Q37248763-DE962FA1-4FFD-454F-9F2C-E59C7CB24FF2

Q37248763-E7DC9536-1555-4805-B1C9-6FD77457A38F

P2860

Q37248763-09495726-4EB1-4B2C-901D-3EA53644CA5B

Q37248763-143E0584-71CB-4C3D-BC56-1E2362412877

Q37248763-15ED6A49-731E-4147-AD30-F7AA7A2D5057

Q37248763-18FDA60B-EC08-4E54-A1F1-5AA19DAA8298

Q37248763-2E7DFF30-BC97-4537-9B3E-C88FE2C95F9C

Q37248763-49B3F418-1A67-4B1A-B19C-E722A562360D

Q37248763-4C3B6B0C-B605-4C0B-85F6-D77B90553A08

Q37248763-4CB16176-1D45-41EB-BEEF-1F4760F4115B

Q37248763-5BDDB362-A0B3-4DB8-A68F-4FC3F355B1D0

Q37248763-846147A0-D5F4-4733-91AC-76DAE61096B3

P304

Q37248763-16C8A41B-33F5-48C3-947F-DF887C81907A

P31

Q37248763-62832296-E45D-47CD-B228-E120D29D3C2D

P356

Q37248763-549D5362-141A-419A-81EC-9FE040DA0509

P407

Q37248763-22B0BB68-0D5E-430C-AD33-A83446179271

P433

Q37248763-18038D57-214F-47A2-8CD8-C72EB39D0CB3

P478

Q37248763-C4520772-6833-4B29-8391-26A807385EED

P577

Q37248763-5572F42C-2C9E-4DDF-A4E5-C4E6B116E7DC

P698

Q37248763-0EC9D329-A2D3-4EC2-84A3-7A7A4C756118

P932

Q37248763-F71EDCBC-D516-4F75-997A-521AAFBD802F

P356

P1433

World Journal of Gastroenterology

P1476

Stronger inhibition of gastric ...... n pump inhibitor lansoprazole.

@en

P2093

Akira Imatani

http://www.w3.org/2001/XMLSchema#string

Hatsushi Yamagishi

http://www.w3.org/2001/XMLSchema#string

Junichi Goto

http://www.w3.org/2001/XMLSchema#string

Kaori Suzuki

http://www.w3.org/2001/XMLSchema#string

Katsunori Iijima

http://www.w3.org/2001/XMLSchema#string

Ryousuke Kikuchi

http://www.w3.org/2001/XMLSchema#string

Shigeyuki Kobayashi

http://www.w3.org/2001/XMLSchema#string

Shuichi Ohara

http://www.w3.org/2001/XMLSchema#string

Takanori Hishinuma

http://www.w3.org/2001/XMLSchema#string

Tomoyuki Koike

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese

The pharmacology of the gastric acid pump: the H+,K+ ATPase

Real time quantitative PCR

Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19

Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations

Early heartburn relief with proton pump inhibitors: a systematic review and meta-analysis of clinical trials.

Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?

Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: on-demand treatment compared with continuous treatment.

Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.

Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.

P304

2406-2410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.14.2406

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18416470

http://www.w3.org/2001/XMLSchema#string

P932

2705098

http://www.w3.org/2001/XMLSchema#string